Skip to main content
Barts Clinical Trials Unit

Studies

Explore the study-specific links below to see how our research is driving patient care towards a healthier future

Studies
  1. Barts Clinical Trials Unit
  2. Studies/Trials

Current Portfolio

Below are links to all the current studies/trials at the Barts CTU. Please click on the trial you would like to explore!

C-ProMeta-1

C-ProMeta-1 is a clinical study investigating if circulating tumor cells (CTCs) can predict treatment failure after radical prostatectomy.
C-ProMeta-1

DETECT-2

DETECT-2 is a research study aiming to evaluate offering genetic testing to patients diagnosed with bowel, womb, and ovarian cancer at home.
DETECT-2

IBIS Trials

The IBIS-I and IBIS-II trials are international clinical trials investigating drugs to prevent breast cancer in high-risk women.
IBIS Trials

LATTE

LATTE: Long−term Anastrozole vs Tamoxifen Treatment Effects. An epidemiological study following the long-term (beyond ten years) outcomes of patients.
LATTE

TransPRIDE

TransPRIDE:A research study defining normal PSA levels in trans women and non-binary people with prostates to improve early prostate cancer diagnosis.
TransPRIDE

PROTECT-C

PROTECT-C is a research study offering genetic testing to people to see whether they have a genetic change that increases their risk of cancer types.
PROTECT-C

TAPG

TAPG is an retrospective study carried out in patients registered on UK regional cancer registry databases, as having prostate cancer diagnosis.
TAPG

TRANSFORM

The TRANSFORM trial is a large-scale UK research programme designed to find the most effective way to screen men for prostate cancer.
TRANSFORM

Closed Studies:

Here you will find a selection of closed studies to view from the Barts CTU. Please click on the trials you wish to find out more information on!

 

Predictors 5.2

PREDICTORS 5.2 is a study comparing self-collected vaginal and urine samples with clinician-taken samples to assess accuracy of HPV screening methods.
Predictors 5.2

PROVENT

PROVENT: investigates the feasibility of using aspirin and/or Vitamin D3 in men to stop the progression of low to intermediate-risk prostate cancer.
PROVENT

To view the portfolio of our sub-units, click the following links below:

Barts Cardiovascular Clinical Trials Unit (CVCTU)

View the Barts Cardiovascular Clinical Trials Unit (CVCTU)  trials portfolio

Cancer Prevention Trials Unit (CPTU)

View the Cancer Prevention Trials Unit (CPTU) trials portfolio

Experimental Medicine and Rheumatology CTC

View the Experimental Medicine and Rheumatology Clinical Trials Centre (EMRCTC) trials portfolio

Logo of EMR CTU Bart's sub unit
Back to top